GLP-2 weight loss therapy alone does not directly reduce appetite, so candidates should combine it with healthy eating and lifestyle strategies
Jednak pamitaj o tym, e stosujesz go na wasn rk
Twenty-five serious side effects were reported in 18 participants from the placebo arm and seven participants in the treatment arm, most of which were unlikely to be treatment-related
By regulation, it cannot contain any other substances, including agents that inhibit bacterial or microorganism growth
Generally, consuming 1,200 calories per day or fewer is not sustainable and often triggers fatigue
For IBS-D (diarrhea-predominant), common after COVID infection, options include: Rifaximin (550mg three times daily for 14 days) shows moderate evidence of efficacy, with retreatment possible for recurrent symptoms